Dysregulation of inflammasome activation in glioma

JM Sim, JM Park, JS Moon, J Lim - Cell Communication and Signaling, 2023 - Springer
Gliomas are the most common brain tumors characterized by complicated heterogeneity.
The genetic, molecular, and histological pathology of gliomas is characterized by high neuro …

Deconvolution of cell type-specific drug responses in human tumor tissue with single-cell RNA-seq

W Zhao, A Dovas, EF Spinazzi, HM Levitin, MA Banu… - Genome medicine, 2021 - Springer
Background Preclinical studies require models that recapitulate the cellular diversity of
human tumors and provide insight into the drug sensitivities of specific cellular populations …

Elucidating the diversity of malignant mesenchymal states in glioblastoma by integrative analysis

R Chanoch-Myers, A Wider, ML Suva, I Tirosh - Genome medicine, 2022 - Springer
Background Multiple glioblastoma studies have described a mesenchymal (MES) state, with
each study defining the MES program by distinct sets of genes and highlighting distinct …

Modeling nervous system tumors with human stem cells and organoids

J Duan, Y Wang - Cell Regeneration, 2023 - Springer
Nervous system cancers are the 10th leading cause of death worldwide, many of which are
difficult to diagnose and exhibit varying degrees of treatment resistance. The limitations of …

[PDF][PDF] Genetic characterization of stem cell-like cancer cell in the peri-tumoral regions and proliferative lymphocyte in the peripheral blood of patients with …

R Yang, G Huang, J Guo, Y Li, H Song, K Li, G Yi, Z Lin… - 2020 - pdfs.semanticscholar.org
The glioblastoma (GBM) recurrence rate is high, despite multimodal treatment including
surgery, radiotherapy, chemotherapy, and immunotherapy. Most recurrences occur at the …

Discovery of peculiar cells in the peri-tumoral regions and peripheral blood of glioblastoma patients by single cell RNA-sequencing

R Yang, G Huang, J Guo, Y Li, H Song, K Li, G Yi, Z Lin… - bioRxiv, 2020 - biorxiv.org
Recurrence is almost inevitable in glioblastoma (GBM) patients even after aggressive
multimodal therapies. Most recurrences occur at the resection margin that is outside GBM's …